These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 24211838)

  • 21. Synergistic effects of erlotinib and everolimus on bronchial carcinoids and large-cell neuroendocrine carcinomas with activated EGFR/AKT/mTOR pathway.
    Bago-Horvath Z; Sieghart W; Grusch M; Lackner A; Hayden H; Pirker C; Komina O; Węsierska-Gądek J; Haitel A; Filipits M; Berger W; Schmid K
    Neuroendocrinology; 2012; 96(3):228-37. PubMed ID: 22378048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-133b inhibits the growth of non-small-cell lung cancer by targeting the epidermal growth factor receptor.
    Liu L; Shao X; Gao W; Zhang Z; Liu P; Wang R; Huang P; Yin Y; Shu Y
    FEBS J; 2012 Oct; 279(20):3800-12. PubMed ID: 22883469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual-agent molecular targeting of the epidermal growth factor receptor (EGFR): combining anti-EGFR antibody with tyrosine kinase inhibitor.
    Huang S; Armstrong EA; Benavente S; Chinnaiyan P; Harari PM
    Cancer Res; 2004 Aug; 64(15):5355-62. PubMed ID: 15289342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidermal growth factor receptor regulates osteoclast differentiation and survival through cross-talking with RANK signaling.
    Yi T; Lee HL; Cha JH; Ko SI; Kim HJ; Shin HI; Woo KM; Ryoo HM; Kim GS; Baek JH
    J Cell Physiol; 2008 Nov; 217(2):409-22. PubMed ID: 18543257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidermal Growth Factor Receptor Mutation Enhances Expression of Cadherin-5 in Lung Cancer Cells.
    Hung MS; Chen IC; Lung JH; Lin PY; Li YC; Tsai YH
    PLoS One; 2016; 11(6):e0158395. PubMed ID: 27362942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preclinical rationale for PI3K/Akt/mTOR pathway inhibitors as therapy for epidermal growth factor receptor inhibitor-resistant non-small-cell lung cancer.
    Gadgeel SM; Wozniak A
    Clin Lung Cancer; 2013 Jul; 14(4):322-32. PubMed ID: 23332287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. EGFR overexpression induces activation of telomerase via PI3K/AKT-mediated phosphorylation and transcriptional regulation through Hif1-alpha in a cellular model of oral-esophageal carcinogenesis.
    Heeg S; Hirt N; Queisser A; Schmieg H; Thaler M; Kunert H; Quante M; Goessel G; von Werder A; Harder J; Beijersbergen R; Blum HE; Nakagawa H; Opitz OG
    Cancer Sci; 2011 Feb; 102(2):351-60. PubMed ID: 21156006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancement of sensitivity to tumor necrosis factor alpha in non-small cell lung cancer cells with acquired resistance to gefitinib.
    Ando K; Ohmori T; Inoue F; Kadofuku T; Hosaka T; Ishida H; Shirai T; Okuda K; Hirose T; Horichi N; Nishio K; Saijo N; Adachi M; Kuroki T
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8872-9. PubMed ID: 16361577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Roles of MKK1/2-ERK1/2 and phosphoinositide 3-kinase-AKT signaling pathways in erlotinib-induced Rad51 suppression and cytotoxicity in human non-small cell lung cancer cells.
    Ko JC; Ciou SC; Jhan JY; Cheng CM; Su YJ; Chuang SM; Lin ST; Chang CC; Lin YW
    Mol Cancer Res; 2009 Aug; 7(8):1378-89. PubMed ID: 19671683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dimerization and the signal transduction pathway of a small in-frame deletion in the epidermal growth factor receptor.
    Sakai K; Arao T; Shimoyama T; Murofushi K; Sekijima M; Kaji N; Tamura T; Saijo N; Nishio K
    FASEB J; 2006 Feb; 20(2):311-3. PubMed ID: 16373402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of the epidermal growth factor receptor gene expression in a morphological variant isolated from an epidermal growth factor receptor-deficient small cell lung carcinoma cell line.
    Gamou S; Shimosato Y; Shimizu N
    Cell Growth Differ; 1990 Aug; 1(8):351-9. PubMed ID: 1980602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Knockdown of integrin α3β1 expression induces proliferation and migration of non-small cell lung cancer cells.
    Yoon HJ; Cho YR; Joo JH; Seo DW
    Oncol Rep; 2013 Feb; 29(2):662-8. PubMed ID: 23233127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin-8 stimulates cell proliferation in non-small cell lung cancer through epidermal growth factor receptor transactivation.
    Luppi F; Longo AM; de Boer WI; Rabe KF; Hiemstra PS
    Lung Cancer; 2007 Apr; 56(1):25-33. PubMed ID: 17175059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential constitutive activation of the epidermal growth factor receptor in non-small cell lung cancer cells bearing EGFR gene mutation and amplification.
    Okabe T; Okamoto I; Tamura K; Terashima M; Yoshida T; Satoh T; Takada M; Fukuoka M; Nakagawa K
    Cancer Res; 2007 Mar; 67(5):2046-53. PubMed ID: 17332333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. YBX1 regulates tumor growth via CDC25a pathway in human lung adenocarcinoma.
    Zhao S; Wang Y; Guo T; Yu W; Li J; Tang Z; Yu Z; Zhao L; Zhang Y; Wang Z; Wang P; Li Y; Li F; Sun Z; Xuan Y; Tang R; Deng WG; Guo W; Gu C
    Oncotarget; 2016 Dec; 7(50):82139-82157. PubMed ID: 27384875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Growth and survival of lung cancer cells: regulation by kallikrein-related peptidase 6 via activation of proteinase-activated receptor 2 and the epidermal growth factor receptor.
    Michel N; Heuzé-Vourc'h N; Lavergne E; Parent C; Jourdan ML; Vallet A; Iochmann S; Musso O; Reverdiau P; Courty Y
    Biol Chem; 2014 Sep; 395(9):1015-25. PubMed ID: 24643912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CEBPγ facilitates lamellipodia formation and cancer cell migration through CERS6 upregulation.
    Shi H; Niimi A; Takeuchi T; Shiogama K; Mizutani Y; Kajino T; Inada K; Hase T; Hatta T; Shibata H; Fukui T; Chen-Yoshikawa TF; Nagano K; Murate T; Kawamoto Y; Tomida S; Takahashi T; Suzuki M
    Cancer Sci; 2021 Jul; 112(7):2770-2780. PubMed ID: 33934437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CHCHD2 Is Coamplified with EGFR in NSCLC and Regulates Mitochondrial Function and Cell Migration.
    Wei Y; Vellanki RN; Coyaud É; Ignatchenko V; Li L; Krieger JR; Taylor P; Tong J; Pham NA; Liu G; Raught B; Wouters BG; Kislinger T; Tsao MS; Moran MF
    Mol Cancer Res; 2015 Jul; 13(7):1119-29. PubMed ID: 25784717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristics of TGFBR1-EGFR-CTNNB1-CDH1 Signaling Axis in Wnt-Regulated Invasion and Migration in Lung Cancer.
    Liu R; Zhang Y; Ding Y; Zhang S; Pan L
    Cell Transplant; 2020; 29():963689720969167. PubMed ID: 33231090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcriptional activation of NANOG by YBX1 promotes lung cancer stem-like properties and metastasis.
    Guo T; Kong J; Liu Y; Li Z; Xia J; Zhang Y; Zhao S; Li F; Li J; Gu C
    Biochem Biophys Res Commun; 2017 May; 487(1):153-159. PubMed ID: 28400280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.